Teza Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History
Teza Capital Management LLC
- $746 Million
- Q1 2024
A detailed history of Teza Capital Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 5,293 shares of RARE stock, worth $225,217. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,293Holding current value
$225,217% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
290Shares Held
78.6MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$370 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.09MShares$302 Million5.31% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$223 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$174 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$164 Million0.53% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.98B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...